9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE, MD
Changes in Board, Management or Compensation, Shareholder votes
Investor Presentation
Provides Business Update and Reports First Quarter 2026 Financial Results
Provides Business Update and Reports Full Year 2025 Financial Results
NextCure, Inc. Enters $14.5 Million ATM Offering Agreement
Announces Closing of $21.5 Million PIPE Financing in Advance of First Half 2026 Phase 1 POC Data Readouts
Provides Business Update and Reports Third Quarter 2025 Financial Results
Q1
FY 2025
Q3
Q2
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Notice of Exempt Offering of Securities
Registration Statement for Securities Offered under a Shelf Registration
Prospectus Filed Pursuant to Rule 424(b)(2)
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Prospectus Filed Pursuant to Rule 424(b)(1)
Correspondence
Submission Upload